Preparing the market for the evolving biosimilar landscape
With more biosimilars and the first major influx of interchangeable inflammatory biosimilars coming to market, proactive education and outreach will be crucial for successful conversions to low-cost o...
Read MoreExpress Scripts in 2023: Supporting clients, patients, and health plans
Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.
Read MoreExpress Scripts Introduces New Option to Give Clients Maximum Simplicity in Drug Pricing
Express Scripts ClearNetwork offers employers and health plans a new option for simple, “cost-plus” pharmacy pricing for brand, generic, and specialty medications.
Read MoreHere’s what drug makers don’t want you to know about PBMs
Pharmacy benefit managers shield patients from higher drug prices, but drug makers don’t want you to know that.
Read MoreClinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreExpress Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Read More
Experts share strategies for improving health care experiences and outcomes
Panelists at the Evernorth Outcomes conference discussed ways they have approached some of today’s biggest challenges in the health care industry – including fragmented care systems, pharmacy costs, a...
Read MoreExpress Scripts launches new initiative to expand rural health care access through partnerships with independent pharmacies
Express Scripts announced key efforts to expand access to health care in rural communities through partnerships with independent pharmacies across the U.S.
Read MoreWhat to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read More